Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Scadden

Showing results (281-290 of 311) with videos related to

Pageof 32
Sort By:
Nature|February 28, 2020
Lipid availability determines fate of skeletal progenitor cells via SOX9Nick van Gastel, Steve Stegen, Guy Eelen, et al.
The Journal of Clinical Investigation|January 26, 2008
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in miceSiddhartha Mukherjee, Noopur Raje, Jesse A Schoonmaker, et al.
Blood|September 10, 2014
Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioningBorja Saez, Francesca Ferraro, Rushdia Z Yusuf, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cell Metabolism|June 12, 2025
Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogrammingTing Zhao, Lingli He, Lai Ping Wong, et al.
Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.
Genome Medicine|January 28, 2024
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesionsShenglin Mei, Adele M Alchahin, Ioanna Tsea, et al.
Nature|March 15, 2013
Differential stem- and progenitor-cell trafficking by prostaglandin E2Jonathan Hoggatt, Khalid S Mohammad, Pratibha Singh, et al.
Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Cell Stem Cell|August 16, 2016
Proximity-Based Differential Single-Cell Analysis of the Niche to Identify Stem/Progenitor Cell RegulatorsLev Silberstein, Kevin A Goncalves, Peter V Kharchenko, et al.
Pageof 32

Showing results (281-290 of 311) with videos related to

Sort By:
Pageof 32
Nature|February 28, 2020
Lipid availability determines fate of skeletal progenitor cells via SOX9Nick van Gastel, Steve Stegen, Guy Eelen, et al.
The Journal of Clinical Investigation|January 26, 2008
Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in miceSiddhartha Mukherjee, Noopur Raje, Jesse A Schoonmaker, et al.
Blood|September 10, 2014
Inhibiting stromal cell heparan sulfate synthesis improves stem cell mobilization and enables engraftment without cytotoxic conditioningBorja Saez, Francesca Ferraro, Rushdia Z Yusuf, et al.
Cancer Cell|January 16, 2007
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patientsTracy T Batchelor, A Gregory Sorensen, Emmanuelle di Tomaso, et al.
Cell Metabolism|June 12, 2025
Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogrammingTing Zhao, Lingli He, Lai Ping Wong, et al.
Blood|March 6, 2024
Alloengraftment without significant toxicity or GVHD in CD45 antibody-drug conjugate-conditioned Fanconi anemia miceAsim Saha, Rahul Palchaudhuri, Leanne Lanieri, et al.
Genome Medicine|January 28, 2024
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesionsShenglin Mei, Adele M Alchahin, Ioanna Tsea, et al.
Nature|March 15, 2013
Differential stem- and progenitor-cell trafficking by prostaglandin E2Jonathan Hoggatt, Khalid S Mohammad, Pratibha Singh, et al.
Blood|August 18, 2023
PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancyPeter G Miller, Adam S Sperling, Christina Mayerhofer, et al.
Cell Stem Cell|August 16, 2016
Proximity-Based Differential Single-Cell Analysis of the Niche to Identify Stem/Progenitor Cell RegulatorsLev Silberstein, Kevin A Goncalves, Peter V Kharchenko, et al.
Pageof 32